UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug discovery and development: Role of basic biological research

Alzheimer's & dementia : translational research & clinical interventions, 2017-11, Vol.3 (4), p.651-657

2017

Volltextzugriff (PDF)

Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function

Cell metabolism, 2016-08, Vol.24 (2), p.332-340

2016

Volltextzugriff (PDF)

Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms

Trends in neurosciences (Regular ed.), 2017-03, Vol.40 (3), p.151-166

2017

Volltextzugriff (PDF)

Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury

Current neuropharmacology, 2023-01, Vol.21 (4), p.1001-1012

2023

Volltextzugriff (PDF)

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

CNS & neurological disorders drug targets, 2014-01, Vol.13 (8), p.1432-1439

2014

Volltextzugriff (PDF)

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease

Current Alzheimer research, 2012-07, Vol.9 (6), p.746-758

2012

Volltextzugriff (PDF)

Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases

CNS & neurological disorders drug targets, 2011-05, Vol.10 (3), p.391-403

2011

Volltextzugriff (PDF)

Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment

Frontiers in psychiatry, 2021-03, Vol.12, p.536257-536257

2021

Volltextzugriff (PDF)

nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse

Scientific reports, 2021-05, Vol.11 (1), p.9711-9711, Article 9711

2021

Volltextzugriff (PDF)

Neuroprotective and neurotrophic actions of glucagon‐like peptide‐1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders

British journal of pharmacology, 2012-07, Vol.166 (5), p.1586-1599

2012

Volltextzugriff (PDF)

Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease

Current medicinal chemistry, 2023, Vol.30 (3), p.255-270

2023

Volltextzugriff (PDF)

Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model

PloS one, 2018-08, Vol.13 (8), p.e0201022

2018

Volltextzugriff (PDF)

Neuroinflammation in animal models of traumatic brain injury

Journal of neuroscience methods, 2016-10, Vol.272, p.38-49

2016

Volltextzugriff (PDF)

Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments

Frontiers in cell and developmental biology, 2019-12, Vol.7, p.313

2019

Volltextzugriff (PDF)

TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation

Journal of neuroinflammation, 2012-01, Vol.9 (1), p.23-23, Article 23

2012

Volltextzugriff (PDF)

Relative synonymous codon usage and codon pair analysis of depression associated genes

Scientific reports, 2024-02, Vol.14 (1), p.3502-3502, Article 3502

2024

Volltextzugriff (PDF)

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

Current pharmaceutical design, 2016-01, Vol.22 (5), p.527-534

2016

Volltextzugriff (PDF)

Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice

Journal of neurochemistry, 2015-12, Vol.135 (6), p.1203-1217

2015

Volltextzugriff (PDF)

Traumatic brain injury increases plasma astrocyte‐derived exosome levels of neurotoxic complement proteins

The FASEB journal, 2020-02, Vol.34 (2), p.3359-3366

2020

Volltextzugriff (PDF)

Current Intellectual Glance Over Nanoparticles in Cancer and Neurodegenerative Research

Current medicinal chemistry, 2023, Vol.30 (3), p.251-254

2023

Volltextzugriff (PDF)

Insulin resistance and exendin-4 treatment for multiple system atrophy

Brain (London, England : 1878), 2017-05, Vol.140 (5), p.1420-1436

2017

Volltextzugriff (PDF)

Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease

Expert opinion on investigational drugs, 2020-06, Vol.29 (6), p.595-602

2020

Volltextzugriff (PDF)

Genetic and Molecular Regulations of Neuronal Activity

International journal of molecular sciences, 2023-11, Vol.24 (22), p.16191

2023

Volltextzugriff (PDF)

Proteomic Signature and mRNA Expression in Hippocampus of SAMP8 and SAMR1 Mice during Aging

International journal of molecular sciences, 2022-12, Vol.23 (23), p.15097

2022

Volltextzugriff (PDF)

Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective

Current Alzheimer research, 2017-01, Vol.14 (11), p.1164

2017

Volltextzugriff (PDF)

1 – 25 von 516

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(489)
Mit Volltextzugriff
(409)

Publikationsform

Sprache

Englisch
(515)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Drug discovery and development: Role of basic biological research

Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function

Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms

Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease

Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases

Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment

nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse

Neuroprotective and neurotrophic actions of glucagon‐like peptide‐1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders

Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease

Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model

Neuroinflammation in animal models of traumatic brain injury

Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments

TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation

Relative synonymous codon usage and codon pair analysis of depression associated genes

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice

Traumatic brain injury increases plasma astrocyte‐derived exosome levels of neurotoxic complement proteins

Current Intellectual Glance Over Nanoparticles in Cancer and Neurodegenerative Research

Insulin resistance and exendin-4 treatment for multiple system atrophy

Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease

Genetic and Molecular Regulations of Neuronal Activity

Proteomic Signature and mRNA Expression in Hippocampus of SAMP8 and SAMR1 Mice during Aging

Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective

Suchergebnisse filtern